(Q33374654)

26 July 2017

title

Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

2

Laura J Havrilesky

1 reference

26 July 2017

7

Andrew Berchuck

1 reference

26 July 2017

3

Michael E Carney

1 reference

26 July 2017

author name string

Angeles Alvarez Secord

1

1 reference

26 July 2017

John T Soper

4

1 reference

26 July 2017

Daniel L Clarke-Pearson

5

1 reference

26 July 2017

Gustavo C Rodriguez

6

1 reference

26 July 2017

language of work or name

1 reference

25 February 2007

1 reference

International Journal of Clinical Oncology

26 July 2017

published in

1 reference

26 July 2017

volume

12

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

31-36

1 reference

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

26 July 2017

cites work

1 reference

12 December 2020

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

1 reference

12 December 2020

Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum.

1 reference

12 December 2020

Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.

1 reference

12 December 2020

Multicenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatin

1 reference

12 December 2020

Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects

1 reference

12 December 2020

Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer

1 reference

12 December 2020

Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center.

1 reference

12 December 2020

Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience

1 reference

12 December 2020

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

12 December 2020

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

12 December 2020

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

1 reference

12 December 2020

Weekly dosing of carboplatin increases risk of allergy in children.

1 reference

12 December 2020

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer

1 reference

12 December 2020

Weekly paclitaxel in the management of ovarian cancer

1 reference

12 December 2020

The role of optimal debulking in advanced stage serous carcinoma of the uterus

1 reference

12 December 2020

10.1007/S10147-006-0619-9

Identifiers

DOI

1 reference

26 July 2017

1 reference